Laurent Pharmaceuticals is a private biopharmaceutical company developing a clinical stage, orally-active drug candidate with potential to modulate the immuno-inflammatory response in Cystic Fibrosis patients.


Founded in Montréal in 2012, Laurent Pharmaceuticals emerged from a partnership between MSBi Valorisation (MSBiV), an early-stage Montréal-based investor, McGill University (McGill) and the Research Institute of the McGill University Health Centre (RI-MUHC). Initially financed by MSBiV, the company leveraged subsequent funding from other private investors, including Anges Quebec, US Cystic Fibrosis Foundation Therapeutics and Cystic Fibrosis Canada.

Laurent Pharmaceuticals is looking for financial partners for its upcoming Phase 2 clinical trails. If interested, please contact Radu Pislariu at This email address is being protected from spambots. You need JavaScript enabled to view it.